Concepedia

Rabindra V. Shivnaraine

RV

Statistics

Publications

9

Citations

555

H-Index

9

Active since

2014

Affiliations

Stanford University(Current)

Cardiovascular Institute of the South

University of Toronto

Carleton College

System Biosciences (United States)

Rabindra V. Shivnaraine is an author at Stanford University specializing in pharmacology, receptor-ligand interactions, and ligand binding.

Publications per year

2014–2024

9

Publications

9

ADMET-AI: a machine learning ADMET platform for evaluation of large-scale chemical libraries

Kyle Swanson, Parker Walther, Jeremy Leitz et al. · Bioinformatics · 2024 · 246 citations · Full text

, , +16

Multiscale drug screening for cardiac fibrosis identifies MD2 as a therapeutic target

Hao Zhang, Phung N. Thai, Rabindra V. Shivnaraine et al. · Cell · 2024 · 66 citations · Full text

, , +14

SGLT2 inhibitor ameliorates endothelial dysfunction associated with the common<i>ALDH2</i>alcohol flushing variant

Hongchao Guo, Xuan Yu, Yu Liu et al. · Science Translational Medicine · 2023 · 51 citations · Full text

, , +17

FDA Modernization Act 2.0 Paves the Way to Computational Biology and Clinical Trials in a Dish

Syed Mukhtar Ahmed, Rabindra V. Shivnaraine, Joseph C. Wu · Circulation · 2023 · 43 citations · Full text

, , +16

ADMET-AI: A machine learning ADMET platform for evaluation of large-scale chemical libraries

Kyle Swanson, Parker Walther, Jeremy Leitz et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2023 · 37 citations · Full text

, , +16

1–5 of 9